Coverage of several self-administered DMARDs declined across Medicare Part D plans between 2022 and 2026, with differential coverage noted across plan types.

New EULAR recommendations for the management of rheumatoid arthritis stress that disease-modifying antirheumatic drugs should ...

Please provide your email address to receive an email when new articles are posted on . JAK inhibitors were not linked to increased cardiovascular complications vs. TNF inhibitors or other DMARDs in ...

Clinicians looking for a fresh and authoritative guide to drug treatment for psoriatic arthritis (PsA) can thank the European Alliance of Associations for Rheumatology (EULAR), which just published an ...